AI doesn’t diagnose on its own. But it can influence the process around diagnosis. In real Sheridan cases, AI-related issues often show up indirectly—through how information is routed, how risk is scored, how imaging is summarized, or how clinical decision prompts are documented.
Common local scenarios we investigate include:
- Delayed recognition after repeat visits: A patient returns with worsening symptoms, but the earlier visit didn’t lead to escalation or the right follow-up.
- Imaging or lab workflow problems: Imaging summaries, flagged findings, or lab interpretations may not have been integrated into the clinician’s reasoning quickly enough.
- Triage and documentation shortcuts: Tools used to assist with intake or clinical documentation can shape what clinicians notice—and what they don’t.
- Miscommunication between facilities/providers: Sheridan patients sometimes receive care across multiple settings (clinic, ER, specialty follow-up). Breakdown in handoff documentation can turn a borderline call into a missed diagnosis.
The key is not whether a tool was used. The key is whether clinicians and the facility acted reasonably with the information available at the time.


